Similar to This
Previous

Slightly improved relapse control of ocrelizumab in multiple sclerosis - | Deutsches Ärzteblatt
aerzteblatt.de/news/leicht-verbesserte-ruckfallkontrolle-von-ocrelizumab-bei-multipler-sklerose-2639462e-21b1-4808-b6cf-91cb285b3439

Multiple sclerosis: Tolebrutinib possibly the first therapeutic agent for a rare form - | Deutsches Ärzteblatt
aerzteblatt.de/news/multiple-sklerose-tolebrutinib-moglicherweise-erstes-therapeutikum-bei-seltener-form-6547a854-47af-4dd3-a44f-fa7467264f66

Genetics together with immune response against EBV could increase the risk of multiple sclerosis - | Deutsches Ärzteblatt
aerzteblatt.de/news/genetik-zusammen-mit-immunantwort-gegen-ebv-konnte-risiko-fur-multiple-sklerose-erhohen-bc82efaf-92f5-4a49-abad-159457c37c95
Mothers with MS: Increased risk of mental illness before and after birth: Halifax – Mothers with multiple sclerosis (MS) are more likely to develop new mental ...
aerzteblatt.de/nachrichten/157085/Muetter-mit-MS-Erhoehtes-Risiko-fuer-psychische-Erkrankungen-vor-und-nach-der-Geburt
Relapses after discontinuing disease-modifying therapy even in cases of long-term stable MS
aerzteblatt.de/nachrichten/156429/Rezidive-nach-Absetzen-der-verlaufsmodifizierenden-Therapie-auch-bei-lange-stabiler-MS
Protection from parental smoking could protect susceptible children from later multiple sclerosis
aerzteblatt.de/nachrichten/156513/Schutz-vor-elterlichem-Rauchen-koennte-suszeptible-Kinder-vor-spaeterer-Multipler-Sklerose-bewahren
DMSKW Register: How safe are MS medications during pregnancy?: Bochum - Some active ingredients used in the disease-modifying therapy of multiple sclerosis (MS) ...
aerzteblatt.de/nachrichten/156196/DMSKW-Register-Wie-sicher-sind-MS-Medikamente-in-der-Schwangerschaft
Early changes in the immune system in multiple sclerosis: Munich – In multiple sclerosis (MS), CD8 T cells are already active at a time when the disease does not ...
aerzteblatt.de/nachrichten/154969/Fruehe-Veraenderungen-im-Immunsystem-bei-Multipler-Sklerose
Old retroviruses in the genome increase the risk of MS and ALS: London – The relics of human endogenous retroviruses (HERV), which entered the human genome in ...
aerzteblatt.de/nachrichten/155168/Alte-Retroviren-im-Erbgut-erhoehen-Risiko-auf-MS-und-ALS
Multiple sclerosis: New MRI lesions indicate intensification of therapy even without clinical deterioration
aerzteblatt.de/nachrichten/154231/Multiple-Sklerose-Neue-MRT-Laesionen-sprechen-auch-ohne-klinische-Verschlechterung-fuer-Intensivierung-der-Therapie
OCT parameters could be useful as biomarkers in multiple sclerosis: Rome – Despite technological advances, there are currently only a few prognostic biomarkers ...
aerzteblatt.de/nachrichten/152806/OCT-Parameter-koennten-als-Biomarker-bei-Multipler-Sklerose-nuetzlich-sein
Paid articlePaywall Multiple sclerosis: "I wanted to push away all the people I loved": Multiple sclerosis at 30? It can't be, thought Sarah Ploss. But she accepted the illness and ...
zeit.de/sinn/2024-05/multiple-sklerose-diagnose-krankheit-immuntherapie
Autoantibody signature suitable for early detection of multiple sclerosis?: San Francisco - Years before the first clinical symptoms of multiple sclerosis (MS) ...
aerzteblatt.de/nachrichten/150928/Autoantikoerpersignatur-zur-Frueherkennung-von-Multipler-Sklerose-geeignet
It is better to continue highly effective therapy even with non-active MS: Strasbourg - In patients with non-active multiple sclerosis (MS) aged 50 and over ...
aerzteblatt.de/nachrichten/150302/Hochwirksame-Therapie-auch-bei-nicht-aktiver-MS-besser-fortsetzen
Multiple sclerosis: Frexalimab blocks both arms of the immune system and prevents new lesions at an early stage
aerzteblatt.de/nachrichten/149320/Multiple-Sklerose-Frexalimab-blockiert-beide-Arme-der-Immunabwehr-und-verhindert-fruehzeitig-neue-Laesionen
Archaeogenetics: Multiple sclerosis comes from the Asian steppe: Copenhagen - The gene variants in the HLA region, which increase the risk of multiple sclerosis ...
aerzteblatt.de/nachrichten/148545/Archaeogenetik-Multiple-Sklerose-kommt-aus-der-asiatischen-Steppe

Merck: Study flop with multiple sclerosis drug evobrutinib drags down shares: A study flop and its consequences: Merck's multiple sclerosis drug is not producing ...
wiwo.de/unternehmen/industrie/pharma-das-ist-ein-schwerer-rueckschlag-fuer-merck/29542884.html
Researchers recommend stem cell therapy for highly active multiple sclerosis: Uppsala - A working group at Uppsala University in Sweden advocates for stem cell ...
aerzteblatt.de/nachrichten/146494/Forscher-empfehlen-Stammzelltherapie-bei-hochaktiver-Multipler-Sklerose
Early therapy for multiple sclerosis could delay later disabilities: Barcelona - In patients who develop within 6 months of the onset of symptoms ...
aerzteblatt.de/nachrichten/144807/Fruehzeitige-Therapie-der-Multiplen-Sklerose-koennte-spaetere-Behinderungen-hinauszoegern

Multiple sclerosis: Experiences with treatment discontinuation in old age: Aurora/Colorado - When the number of disease flares decreases with age and the ...
aerzteblatt.de/nachrichten/144207/Multiple-Sklerose-Erfahrungen-zum-Behandlungsabbruch-im-Alter
Next